Physical Activity and Sexuality After Reduction Mammaplasty
Satisfaction, Physical Activity and Sexuality Outcomes in Breast Reduction Patients
2 other identifiers
interventional
60
1 country
1
Brief Summary
This prospective controlled trial was designed to determine whether breast reduction may influence physical activity and sexuality of breast hypertrophy women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 16, 2011
CompletedFirst Posted
Study publicly available on registry
February 17, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedJuly 9, 2013
July 1, 2013
2.8 years
February 16, 2011
July 5, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
physical activity
Physical activity will be assessed by a validated instrument, the International Physical Activity Questionnaire (IPAQ), at pre-operative and 6 months after breast reduction
6 months
Secondary Outcomes (2)
Patient's satisfaction
6 months
Sexuality
6 months
Study Arms (2)
Breast reduction
EXPERIMENTALBreast hypertrophy women allocated to this arm will undergo reduction mammaplasty
Control
OTHERPatients in this arm will be assessed twice, without surgical intervention
Interventions
Eligibility Criteria
You may qualify if:
- breast hypertrophy
- candidate to reduction mammaplasty
- body mass index under 30Kg/m2
- women with sexual activity
You may not qualify if:
- pregnancy, delivery or breast feeding during the last 12 months
- body mass index over 30Kg/m2
- breast cancer history
- previous breast surgery
- smoking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital São Paulo
São Paulo, São Paulo, 04024002, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vanessa L Resende, MD
Federal University of São Paulo
- STUDY DIRECTOR
Miguel Sabino-Neto, MD, PhD
Federal University of São Paulo
- STUDY DIRECTOR
Daniela F Veiga, MD, PhD
Federal University of São Paulo
- STUDY CHAIR
Lydia M Ferreira, MD, PhD
Federal University of São Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 16, 2011
First Posted
February 17, 2011
Study Start
May 1, 2010
Primary Completion
February 1, 2013
Study Completion
June 1, 2013
Last Updated
July 9, 2013
Record last verified: 2013-07